~~<i id='04462D2D3B'><strike id='04462D2D3B'><tt id='04462D2D3B'><pre id='04462D2D3B'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

focus

fashion

author：focus 2025-10-04 03:59:43 - browse：7261

Eli Lilly headquarters in Indianapolis – pharmaceutical coverage from STAT — Darron Cummings/AP

A couple billion here, a couple billion there, and pretty soon Eli Lilly hopes it will be talking about real money.

Eli Lilly agreed to purchase Point Biopharma Tuesday morning for $1.4 billion, a 90% premium, adding to its pipeline of cancer drugs. Point is developing cancer drugs that deliver a focused dose of radiation to tumor cells. Data for its lead medicine, for prostate cancer, are expected in the fourth quarter. It is also developing a drug for neuroendocrine tumors.

Point operates a 180,000-square-foot radiopharmaceutical manufacturing facility in Indianapolis, and a radiopharmaceutical research and development center in Toronto.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： FDA approval of Sarepta Duchenne genetic therapy gives me hope
Next article： VC firm General Catalyst wants to buy a health system

focus

leisure time

knowledge

focus

entertainment

AdobeThekidneysaresomeofthemostarchitecturallycomplexorgansinthehumanbody—intricateinawaythatbecomes

WSS

Resistance to cancer drugs: A new genetic explanation

Chan Zuckerberg Biohub Chicago to focus on inflammation

Trump got a 'target letter.' What is one and what does it mean?

Celebrate National Dole Whip Day for 3 days this week at Disney

New warning issued for rebooking air travel after delays, cancellations

Was Amgen transparent enough on FDA's concern on cancer drug?

focus

fashion

focus

Alkermes shareholders re

Chemotherapy drug shortage eases slightly but still widespread

Trump demands the U.S. pay no more for drugs than other countries … again

A Q&A with the global head of Boehringer Ingelheim's innovation unit

Medical records are filled with copy

Phenylephrine and the overlooked value of the placebo effect

In age of alternative facts, a scholarly course on calling out crap

Russia strikes Ukraine's critical port facilities in Odesa after halting grain deal

New air purifier tech could be key to improving indoor air quality

Bill would stop addiction treatment from triggering child abuse inquiry

leisure time

Couple fighting to bring baby home from Mexico are finally reunited

AI can decode, harness the power of the humane immune system

Phenylephrine and the overlooked value of the placebo effect

Gilgo Beach murders: What questions remain following Rex Heuermann's arrest?

Stanford president to resign after investigation of research

AI can decode, harness the power of the humane immune system

leisure time

knowledge

focus

entertainment